CHO Talks: A deep dive into expression approaches for biotherapeutics

Experts from Lonza and Denmark Technical University share the key considerations of selecting an expression format during biotherapeutic development.

04/23/2024

Subscribe for free:

Discussing the use of different expression formats, from transient through to stable clones, when using Chinese Hamster Ovary cells for biotherapeutic protein production, experts from Lonza and Denmark Technical University share the key considerations of selecting an expression format during biotherapeutic development, and how Lonza’s GS Discovery^® solution addresses these.

Interviewee Biography

Peter O’Callaghan
Head of Expression System Sciences, Licensing & Biologics, Lonza

Bernadette Sweeney
Senior Director, Biologics R&D, Lonza

Kee Cheung
Senior Director, Regulatory Affairs, Lonza

Bjorn Gunnar Voldborg
Director, Cell Line and Protein Production Facility, Denmark Technical University

^{Image Credit: Shutterstock}

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

All Episodes